Bosh sahifaLUPIN • NSE
add
Lupin Ltd
Yopilish kursi
2 357,30 ₹
Kunlik diapazon
2 297,20 ₹ - 2 361,90 ₹
Yillik diapazon
1 795,20 ₹ - 2 377,60 ₹
Bozor kapitalizatsiyasi
1,06 trln INR
Oʻrtacha hajm
900,42 ming
Narx/foyda
21,18
Dividend daromadliligi
0,52%
Asosiy maydon
NSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 71,68 mlrd | 24,27% |
Joriy xarajat | 33,93 mlrd | 18,38% |
Sof foyda | 11,76 mlrd | 37,47% |
Sof foyda marjasi | 16,40 | 10,59% |
Har bir ulushga tushum | 32,18 | 72,18% |
EBITDA | 21,20 mlrd | 52,17% |
Amaldagi soliq stavkasi | 22,44% | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 62,82 mlrd | 115,71% |
Jami aktivlari | — | — |
Jami passivlari | — | — |
Umumiy kapital | 197,28 mlrd | — |
Tarqatilgan aksiyalar | 456,70 mln | — |
Narxi/balansdagi bahosi | 5,48 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 18,27% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 11,76 mlrd | 37,47% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is primarily a manufacturer of generic drugs, covering therapeutic areas such as paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.The company operates in multiple international markets including the United States, Japan, Europe, and Australia.. Wikipedia
Tashkil etilgan
1968
Bosh ofis
Sayt
Xodimlar soni
24 006
